Wam Total Liab vs Common Stock Shares Outstanding Analysis

WAM Stock

1.50 0.01 0.67%

Wam Capital financial indicator trend analysis is more than just analyzing Wam Capital current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Wam Capital is a good investment. Please check the relationship between Wam Capital Total Liab and its Common Stock Shares Outstanding accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Wam Capital. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Total Liab vs Common Stock Shares Outstanding

Total Liab vs Common Stock Shares Outstanding Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Wam Capital Total Liab account and Common Stock Shares Outstanding. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Wam Capital's Total Liab and Common Stock Shares Outstanding is 0.56. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Common Stock Shares Outstanding in the same time period over historical financial statements of Wam Capital, assuming nothing else is changed. The correlation between historical values of Wam Capital's Total Liab and Common Stock Shares Outstanding is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Wam Capital are associated (or correlated) with its Common Stock Shares Outstanding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock Shares Outstanding has no effect on the direction of Total Liab i.e., Wam Capital's Total Liab and Common Stock Shares Outstanding go up and down completely randomly.

Correlation Coefficient

0.56

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Most indicators from Wam Capital's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Wam Capital current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Wam Capital. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Selling General Administrative is likely to gain to about 63 M in 2024. Tax Provision is likely to gain to about 94.6 M in 2024

	2021	2022	2023	2024 (projected)
Interest Income	1.4M	5.9M	10.1M	10.6M
Net Interest Income	1.4M	5.9M	10.1M	10.6M

Interest Income Net Interest Income

Wam Capital fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Net Debt	Cash	Other Assets	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Total Current Assets	Common Stock	Other Current Liab	Total Current Liabilities	Other Liab	Retained Earnings	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Net Receivables	Short Term Investments	Other Stockholder Equity	Total Liab	Non Current Liabilities Total	Long Term Debt	Other Current Assets	Short Long Term Debt Total	Inventory
Total Assets		1.0	-0.33	0.25	0.31	0.2	0.98	0.81	0.19	0.97	-0.51	0.52	0.33	-0.76	0.78	0.73	-0.76	0.44	0.13	-0.79	0.78	0.58	0.62	0.41	-0.13	-0.69
Total Stockholder Equity	1.0		-0.32	0.24	0.31	0.2	0.98	0.81	0.19	0.98	-0.51	0.5	0.33	-0.77	0.77	0.73	-0.76	0.44	0.13	-0.8	0.75	0.56	0.61	0.39	-0.14	-0.69
Net Debt	-0.33	-0.32		-0.98	0.32	-0.74	-0.41	0.07	-0.74	-0.18	-0.44	-0.52	-0.37	-0.19	-0.2	0.23	-0.26	-0.45	-0.61	-0.15	-0.37	-0.11	-0.51	-0.33	-0.53	-0.3
Cash	0.25	0.24	-0.98		-0.31	0.76	0.33	-0.15	0.76	0.1	0.49	0.55	0.37	0.27	0.14	-0.32	0.33	0.47	0.65	0.22	0.29	-0.01	0.43	0.31	0.61	0.35
Other Assets	0.31	0.31	0.32	-0.31		-0.56	0.13	0.27	-0.57	0.36	-0.59	0.25	-0.19	-0.46	0.31	0.65	-0.67	0.22	-0.57	-0.53	0.1	-0.23	0.04	-0.33	-0.25	-0.68
Cash And Short Term Investments	0.2	0.2	-0.74	0.76	-0.56		0.36	-0.02	1.0	0.06	0.52	0.44	0.51	0.29	0.12	-0.52	0.45	0.37	0.98	0.25	0.17	-0.01	0.21	0.43	0.52	0.41
Common Stock Total Equity	0.98	0.98	-0.41	0.33	0.13	0.36		0.77	0.35	0.94	-0.41	0.49	0.43	-0.69	0.75	0.6	-0.63	0.41	0.3	-0.7	0.74	0.6	0.63	0.46	-0.09	-0.57
Common Stock Shares Outstanding	0.81	0.81	0.07	-0.15	0.27	-0.02	0.77		-0.03	0.87	-0.55	0.19	0.06	-0.85	0.53	0.73	-0.78	0.22	-0.03	-0.78	0.56	0.47	0.12	0.42	-0.32	-0.66
Total Current Assets	0.19	0.19	-0.74	0.76	-0.57	1.0	0.35	-0.03		0.05	0.54	0.44	0.5	0.3	0.12	-0.53	0.46	0.38	0.98	0.26	0.18	-0.01	0.21	0.43	0.52	0.42
Common Stock	0.97	0.98	-0.18	0.1	0.36	0.06	0.94	0.87	0.05		-0.58	0.36	0.18	-0.88	0.69	0.8	-0.83	0.38	0.01	-0.85	0.68	0.56	0.56	0.33	-0.24	-0.71
Other Current Liab	-0.51	-0.51	-0.44	0.49	-0.59	0.52	-0.41	-0.55	0.54	-0.58		0.05	-0.07	0.66	-0.58	-0.81	0.83	0.31	0.51	0.78	-0.29	-0.44	-0.14	0.13	0.45	0.83
Total Current Liabilities	0.52	0.5	-0.52	0.55	0.25	0.44	0.49	0.19	0.44	0.36	0.05		0.54	-0.02	0.65	0.13	-0.2	0.7	0.39	-0.21	0.66	0.0	0.33	0.5	0.33	-0.33
Other Liab	0.33	0.33	-0.37	0.37	-0.19	0.51	0.43	0.06	0.5	0.18	-0.07	0.54		0.21	0.64	-0.07	0.06	0.12	0.51	-0.11	0.31	0.2	0.19	0.44	-0.04	-0.16
Retained Earnings	-0.76	-0.77	-0.19	0.27	-0.46	0.29	-0.69	-0.85	0.3	-0.88	0.66	-0.02	0.21		-0.45	-0.87	0.88	-0.2	0.31	0.82	-0.46	-0.47	-0.37	-0.13	0.41	0.68
Accounts Payable	0.78	0.77	-0.2	0.14	0.31	0.12	0.75	0.53	0.12	0.69	-0.58	0.65	0.64	-0.45		0.58	-0.62	0.23	0.09	-0.64	0.74	0.5	0.44	0.47	-0.26	-0.69
Non Current Assets Total	0.73	0.73	0.23	-0.32	0.65	-0.52	0.6	0.73	-0.53	0.8	-0.81	0.13	-0.07	-0.87	0.58		-0.98	0.1	-0.57	-0.86	0.56	0.52	0.38	0.06	-0.48	-0.89
Non Currrent Assets Other	-0.76	-0.76	-0.26	0.33	-0.67	0.45	-0.63	-0.78	0.46	-0.83	0.83	-0.2	0.06	0.88	-0.62	-0.98		-0.15	0.48	0.9	-0.58	-0.5	-0.33	-0.07	0.43	0.93
Net Receivables	0.44	0.44	-0.45	0.47	0.22	0.37	0.41	0.22	0.38	0.38	0.31	0.7	0.12	-0.2	0.23	0.1	-0.15		0.32	-0.23	0.38	-0.15	0.35	0.26	0.2	-0.13
Short Term Investments	0.13	0.13	-0.61	0.65	-0.57	0.98	0.3	-0.03	0.98	0.01	0.51	0.39	0.51	0.31	0.09	-0.57	0.48	0.32		0.27	0.08	-0.07	0.1	0.42	0.47	0.42
Other Stockholder Equity	-0.79	-0.8	-0.15	0.22	-0.53	0.25	-0.7	-0.78	0.26	-0.85	0.78	-0.21	-0.11	0.82	-0.64	-0.86	0.9	-0.23	0.27		-0.46	-0.45	-0.33	-0.12	0.4	0.83
Total Liab	0.78	0.75	-0.37	0.29	0.1	0.17	0.74	0.56	0.18	0.68	-0.29	0.66	0.31	-0.46	0.74	0.56	-0.58	0.38	0.08	-0.46		0.7	0.57	0.55	0.04	-0.6
Non Current Liabilities Total	0.58	0.56	-0.11	-0.01	-0.23	-0.01	0.6	0.47	-0.01	0.56	-0.44	0.0	0.2	-0.47	0.5	0.52	-0.5	-0.15	-0.07	-0.45	0.7		0.57	0.29	-0.25	-0.45
Long Term Debt	0.62	0.61	-0.51	0.43	0.04	0.21	0.63	0.12	0.21	0.56	-0.14	0.33	0.19	-0.37	0.44	0.38	-0.33	0.35	0.1	-0.33	0.57	0.57		0.12	0.06	-0.28
Other Current Assets	0.41	0.39	-0.33	0.31	-0.33	0.43	0.46	0.42	0.43	0.33	0.13	0.5	0.44	-0.13	0.47	0.06	-0.07	0.26	0.42	-0.12	0.55	0.29	0.12		0.05	-0.06
Short Long Term Debt Total	-0.13	-0.14	-0.53	0.61	-0.25	0.52	-0.09	-0.32	0.52	-0.24	0.45	0.33	-0.04	0.41	-0.26	-0.48	0.43	0.2	0.47	0.4	0.04	-0.25	0.06	0.05		0.4
Inventory	-0.69	-0.69	-0.3	0.35	-0.68	0.41	-0.57	-0.66	0.42	-0.71	0.83	-0.33	-0.16	0.68	-0.69	-0.89	0.93	-0.13	0.42	0.83	-0.6	-0.45	-0.28	-0.06	0.4

Click cells to compare fundamentals

Wam Capital Account Relationship Matchups

Wam Capital fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.3B	1.8B	1.8B	1.8B	1.9B	2.0B
Total Stockholder Equity	1.2B	1.7B	1.7B	1.7B	1.8B	1.9B
Net Debt	(202.5M)	(149.6M)	(230.2M)	(133.7M)	(211.8M)	(222.4M)
Cash	203.4M	149.6M	230.2M	133.7M	211.8M	156.2M
Other Assets	(895.1M)	1.8B	1.8B	1.8B	(3.3M)	(3.1M)
Cash And Short Term Investments	1.2B	191.8M	250.1M	160.8M	211.8M	348.5M
Liabilities And Stockholders Equity	1.3B	1.8B	1.8B	1.8B	1.9B	2.0B
Total Current Assets	1.2B	191.8M	250.1M	160.8M	241.5M	362.5M
Common Stock	1.4B	1.7B	2.1B	2.2B	2.2B	2.3B
Other Current Liab	1.3M	(64.1M)	(42.7M)	(16.5M)	(34.3M)	(32.6M)
Total Current Liabilities	33.8M	94.1M	51.1M	41.8M	34.3M	28.2M
Accounts Payable	31.5M	64.1M	42.7M	16.5M	34.3M	36.1M
Non Current Assets Total	68.5M	1.6B	1.5B	1.6B	1.7B	1.8B
Non Currrent Assets Other	68.5M	(1.6B)	(1.3B)	(1.4B)	(1.5B)	(1.4B)
Net Receivables	20.6M	29.8M	40.2M	56.3M	26.4M	21.9M
Short Term Investments	963.6M	42.2M	19.9M	27.1M	26.2M	24.8M
Total Liab	57.5M	121.3M	59.5M	48.1M	122.5M	128.6M
Accumulated Other Comprehensive Income	44.6M	184.8M	94.8M	102.5M	164.0M	172.2M
Other Current Assets	23.1M	(29.8M)	(40.2M)	(56.3M)	3.3M	3.4M
Net Tangible Assets	1.2B	1.7B	1.7B	1.7B	2.0B	1.4B
Long Term Investments	963.6M	1.6B	1.3B	1.4B	1.5B	1.1B
Capital Stock	1.4B	1.7B	2.1B	2.2B	2.2B	2.0B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Wam Stock Analysis

When running Wam Capital's price analysis, check to measure Wam Capital's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Wam Capital is operating at the current time. Most of Wam Capital's value examination focuses on studying past and present price action to predict the probability of Wam Capital's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Wam Capital's price. Additionally, you may evaluate how the addition of Wam Capital to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC